Benitec Biopharma Inc. Quarterly Return On Assets in % from Q1 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Benitec Biopharma Inc. quarterly/annual Return On Assets history and growth rate from Q1 2021 to Q3 2024.
  • Benitec Biopharma Inc. Return On Assets for the quarter ending September 30, 2024 was -53 %, a 66.5% increase year-over-year.
  • Benitec Biopharma Inc. annual Return On Assets for 2024 was -75.3 %, a 58.9% increase from 2023.
  • Benitec Biopharma Inc. annual Return On Assets for 2023 was -183 %, a 20.5% decline from 2022.
  • Benitec Biopharma Inc. annual Return On Assets for 2022 was -152 %, a 62.2% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -53 +105 +66.5% Jul 1, 2024 Sep 30, 2024
Q2 2024 -75.3 +108 +58.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -128 +52.8 +29.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -143 +20.9 +12.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -158 -6.58 -4.34% Jul 1, 2023 Sep 30, 2023
Q2 2023 -183 -31.1 -20.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -181 -72.3 -66.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -164 -57 -53.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -152 -56.5 -59.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -152 -58.4 -62.2% Apr 1, 2022 Jun 30, 2022
Q1 2022 -108 -4.68 -4.51% Jan 1, 2022 Mar 31, 2022
Q4 2021 -107 Oct 1, 2021 Dec 31, 2021
Q3 2021 -95.1 Jul 1, 2021 Sep 30, 2021
Q2 2021 -93.7 Apr 1, 2021 Jun 30, 2021
Q1 2021 -104 Jan 1, 2021 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.